135 related articles for article (PubMed ID: 4209923)
1. Potential antileprotic agents. 3. Inhibition of mycobacterial dihydrofolic reductase by 2,4-diamino-5-methyl-6-alkylquinazolines.
DeGraw JI; Brown VH; Colwell WT
J Med Chem; 1974 Jul; 17(7):762-4. PubMed ID: 4209923
[No Abstract] [Full Text] [Related]
2. Nitrofurfuryl heterocycles. 12. 4-Amino-6-(5-nitro-2-furyl)isoxazolo(5,4-d)pyrimidines and 4-amino-2-(5-nitro-2-furyl)pyrimido(4,5-d)pyrimidines.
Burch HA; Benjamin LE
J Med Chem; 1974 Apr; 17(4):451-3. PubMed ID: 4151508
[No Abstract] [Full Text] [Related]
3. [Comparative resistance determinations of urinary microbes in various media with special consideration of Bactrim-Roche].
Zechner E
Wien Klin Wochenschr; 1970 May; 82(18):340-3. PubMed ID: 4995770
[No Abstract] [Full Text] [Related]
4. Potential antileprotic agents. 2. Inhibition of mycobacterial dihydrofolic reductase.
DeGraw JI; Brown VH; Colwell WT; Morrison NE
J Med Chem; 1974 Jan; 17(1):144-6. PubMed ID: 4585973
[No Abstract] [Full Text] [Related]
5. Folate antagonists. 12. Antimalarial and antibacterial effects of 2,4-diamino-6-[(aralkyl and alicyclid)thio-, sulfinyl-, and sulfonyl]quinazolines.
Elslager EF; Davoll J; Jacob P; Johnson AM; Johnson J; Werbel LM
J Med Chem; 1978 Jul; 21(7):639-43. PubMed ID: 97382
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo activity of K-130, a dihydrofolate reductase inhibitor, against Mycobacterium leprae.
Dhople AM
Arzneimittelforschung; 1999 Mar; 49(3):267-71. PubMed ID: 10219472
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial action of complexing compounds. The influence of disodium versenate on microorganisms in vitro.
Kośmider S; Rogala D; Kapp-Burzyńska Z
Arch Immunol Ther Exp (Warsz); 1972; 20(6):931-7. PubMed ID: 4197730
[No Abstract] [Full Text] [Related]
8. Antibacterial activity of diaveridine, trimethoprim, and selected sulfonamides in prostatic fluid.
Carroll PT; Robb CA; Tippett LO; Langston JB
Invest Urol; 1971 May; 8(6):686-94. PubMed ID: 4996092
[No Abstract] [Full Text] [Related]
9. Synthesis and biological activity of quinolyl acetic acid derivatives.
Kohl H; de Souza NJ; Desai PD
J Pharm Sci; 1973 Dec; 62(12):2028-30. PubMed ID: 4202681
[No Abstract] [Full Text] [Related]
10. Sensitivity testing with trimethorpim-sulphamethoxazole.
Bushby SR
Med J Aust; 1973 Jun; 1(2):Suppl:10-8. PubMed ID: 4199527
[No Abstract] [Full Text] [Related]
11. The effect of dihydrofolate reductase inhibitors on Mycobacterium Leprae in the mouse foot pad.
Gelber RH; Levy L
Int J Lepr Other Mycobact Dis; 1976; 44(1-2):124-32. PubMed ID: 776847
[No Abstract] [Full Text] [Related]
12. Substituted 1-[(5-nitrofurfurylidene)amino]-4-imidazolin-2-ones.
Snyder HR; Freedman R
J Med Chem; 1975 May; 18(5):524-6. PubMed ID: 807733
[TBL] [Abstract][Full Text] [Related]
13. [Antibacterial action of septrin in vitro against microorganisms causing urinary tract infections in comparison with their sensitivity to other chemotherapeutic and antibiotic drugs].
Ganczarski A; Augustyniak G; Brauner G; Prelich A; Stapor K
Przegl Lek; 1973; 30(3):303-7. PubMed ID: 4633373
[No Abstract] [Full Text] [Related]
14. Sequential blockade of the mycobacterial de novo folate pathway. A review.
Morrison NE
Int J Lepr Other Mycobact Dis; 1971; 39(1):34-43. PubMed ID: 4399473
[No Abstract] [Full Text] [Related]
15. Antimicrobials. New nitrofuran derivatives.
Szarvasi E; Fontaine L; Betbeder-Matibet A
J Med Chem; 1973 Mar; 16(3):281-7. PubMed ID: 4200221
[No Abstract] [Full Text] [Related]
16. [Sensitization test against trimethoprim-sulfamethoxazole].
Tauchnitz C; Tattermann G
Z Gesamte Inn Med; 1972 May; 27(9):390-5. PubMed ID: 4626641
[No Abstract] [Full Text] [Related]
17. Mesoionic purinone analogs. IV. Synthesis and in vitro antibacterial properties of mesoionic thiazolo(3,2-a)pyrimidin-5,7-diones and mesoionic 1,3,4-thiadizolo(3,2-a)pyrimidin-5,7-diones.
Coburn RA; Glennon RA
J Pharm Sci; 1973 Nov; 62(11):1785-9. PubMed ID: 4202220
[No Abstract] [Full Text] [Related]
18. Synthesis of 3'.4'-dideoxyneamine active aginst kanamycin-resistant E. coli and P. aeruginosa.
Umezawa S; Tsuchiya T; Jikihara T; Umezawa H
J Antibiot (Tokyo); 1971 Oct; 24(10):711-2. PubMed ID: 5003479
[No Abstract] [Full Text] [Related]
19. Potential antileprotic agents. 1. Inhibition of a model mycobacterial system by diaryl sulfones.
Colwell WT; Chan G; Brown VH; DeGraw JI; Peters JH; Morrison NE
J Med Chem; 1974 Jan; 17(1):142-4. PubMed ID: 4585972
[No Abstract] [Full Text] [Related]
20. [Laboratory findings on a combination of trimethoprim and sulfamethoxazole].
Legler F
Dtsch Med Wochenschr; 1971 May; 96(19):823-4 passim. PubMed ID: 4396839
[No Abstract] [Full Text] [Related]
[Next] [New Search]
